GlaxoSmithKline Pharmaceuticals Limited (GLAXO) — Cash Flow Reinvestment Rate
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting Rs0.00 (capex Rs0.00 ) from operating cash flow of Rs342.20 Million. Check GLAXO operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
GlaxoSmithKline Pharmaceuticals Limited Cash Flow Reinvestment Rate (2005–2025)
Historical reinvestment intensity for GlaxoSmithKline Pharmaceuticals Limited across 21 annual periods. Explore GlaxoSmithKline Pharmaceuticals Limited (GLAXO) investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for GlaxoSmithKline Pharmaceuticals Limited (2005–2025)
Year-by-year capital reinvestment analysis for GlaxoSmithKline Pharmaceuticals Limited. For live market cap and broader valuation context, see GlaxoSmithKline Pharmaceuticals Limited stock valuation.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.05x | Rs688.30 Million | Rs12.90 Billion | Rs230.20 Million | ▼ -22.2% |
| 2024 | 0.07x | Rs399.33 Million | Rs5.82 Billion | Rs312.21 Million | ▼ -96.1% |
| 2023 | 1.76x | Rs8.52 Billion | Rs4.84 Billion | Rs440.40 Million | ▼ -22.8% |
| 2022 | 2.28x | Rs18.47 Billion | Rs8.11 Billion | Rs346.41 Million | ▲ +389.0% |
| 2021 | 0.47x | Rs2.69 Billion | Rs5.78 Billion | Rs442.27 Million | ▼ -7.8% |
| 2020 | 0.51x | Rs2.48 Billion | Rs4.90 Billion | Rs1.56 Billion | ▼ -35.2% |
| 2019 | 0.78x | Rs3.11 Billion | Rs3.99 Billion | Rs2.91 Billion | ▼ -49.9% |
| 2018 | 1.56x | Rs7.36 Billion | Rs4.73 Billion | Rs4.03 Billion | ▼ -52.7% |
| 2017 | 3.29x | Rs7.76 Billion | Rs2.36 Billion | Rs3.04 Billion | ▼ -42.7% |
| 2016 | 5.74x | Rs7.99 Billion | Rs1.39 Billion | Rs2.32 Billion | ▲ +494.3% |
| 2015 | 0.97x | Rs2.61 Billion | Rs2.70 Billion | Rs1.30 Billion | ▲ +160.0% |
| 2014 | 0.37x | Rs1.05 Billion | Rs2.81 Billion | Rs582.22 Million | ▲ +198.2% |
| 2013 | 0.12x | Rs390.76 Million | Rs3.14 Billion | Rs390.76 Million | ▼ -0.6% |
| 2012 | 0.13x | Rs420.95 Million | Rs3.36 Billion | Rs420.95 Million | ▲ +181.0% |
| 2011 | 0.04x | Rs213.94 Million | Rs4.79 Billion | Rs213.94 Million | ▼ -24.8% |
| 2010 | 0.06x | Rs303.67 Million | Rs5.12 Billion | Rs303.67 Million | ▼ -17.9% |
| 2009 | 0.07x | Rs238.79 Million | Rs3.30 Billion | Rs238.79 Million | ▲ +50.5% |
| 2008 | 0.05x | Rs153.26 Million | Rs3.19 Billion | Rs153.26 Million | ▼ -33.3% |
| 2007 | 0.07x | Rs186.23 Million | Rs2.59 Billion | Rs186.23 Million | ▲ +7.6% |
| 2006 | 0.07x | Rs233.91 Million | Rs3.49 Billion | Rs233.91 Million | ▲ +63.6% |
| 2005 | 0.04x | Rs93.72 Million | Rs2.29 Billion | Rs93.72 Million | — |